Personal care company Nu Skin (NYSE:NUS) will be reporting earnings tomorrow after the bell. Here’s what to expect.
Nu Skin beat analysts’ revenue expectations by 1.7% last quarter, reporting revenues of $439.1 million, down 12.2% year on year. It was a mixed quarter for the company, with an impressive beat of analysts’ EBITDA estimates but underwhelming earnings guidance for the full year.
Is Nu Skin a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Nu Skin’s revenue to decline 11.6% year on year to $441 million, a further deceleration from the 7.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.20 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Nu Skin has missed Wall Street’s revenue estimates five times over the last two years.
Looking at Nu Skin’s peers in the personal care segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Herbalife’s revenues decreased 3.2% year on year, missing analysts’ expectations by 1%, and Medifast reported a revenue decline of 40.6%, topping estimates by 1.5%. Herbalife traded up 10.2% following the results while Medifast was also up 8.6%.
Read our full analysis of Herbalife’s results here and Medifast’s results here.
Investors in the personal care segment have had steady hands going into earnings, with share prices up 1.2% on average over the last month. Nu Skin’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $9.58 (compared to the current share price of $6.43).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefitting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。